Neuberger Berman Group LLC Outset Medical, Inc. Transaction History

Neuberger Berman Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$17.18 - $23.76 $803,319 - $1.11 Million	46,759 Added 45.55%	149,419 $3.27 Million
Q1 2023 May 12, 2023	SELL	$18.25 - $30.26 $102,638 - $170,182	-5,624 Reduced 5.19%	102,660 $1.89 Million
Q4 2022 Feb 13, 2023	BUY	$12.36 - $26.41 $1.34 Million - $2.86 Million	108,284 New	108,284 $2.8 Million
Q2 2022 Aug 15, 2022	BUY	$13.46 - $48.16 $68,322 - $244,460	5,076 Added 3.66%	143,920 $2.14 Million
Q1 2022 May 13, 2022	BUY	$34.22 - $47.24 $554,227 - $765,099	16,196 Added 13.21%	138,844 $6.24 Million
Q4 2021 Feb 11, 2022	SELL	$43.29 - $58.77 $385,281 - $523,053	-8,900 Reduced 6.77%	122,648 $5.54 Million
Q3 2021 Nov 12, 2021	BUY	$36.86 - $54.98 $4.59 Million - $6.85 Million	124,514 Added 1770.17%	131,548 $6.38 Million
Q2 2021 Aug 13, 2021	BUY	$41.49 - $59.92 $291,840 - $421,477	7,034 New	7,034 $352,000

131

39M

65.1K

91.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $32.6M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.